Completed

Phase 3
Age: 25Years - 49Years
All Genders
ID00000519

Led by Stanford University · Updated on 2013-06-26

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

On this page

Sponsors

S

Stanford University

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

To determine the effects in moderately obese subjects of weight loss by combined dieting and exercise training on risk factors for coronary artery disease including lipoprotein lipids, apoproteins and blood pressure.

CONDITIONS

Official Title

Exercise Training and Plasma Lipoproteins in Man

Who Can Participate

Age: 25Years - 49Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Men and women, ages 25-49. Subjects were overweight with blood pressure less than 160/95 mm Hg and total cholesterol less than 260 mm/dl.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

RANDOMIZED

Model

N/A

Primary Purpose

PREVENTION

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise.

P D Wood, M L Stefanick, D M Dreon...

https://pubmed.ncbi.nlm.nih.gov/3173455
Clinical Trial | DecenTrialz